CYCLOBENZAPRINE HYDROCHLORIDE

Product NDC: 87441-010
Requested package NDC: 87441-010-01
11-digit product format: 874410010
Labeler code: 87441
Product ID: 87441-010_53be0bcb-9f2d-ffda-e063-6294a90aac29
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: cyclobenzaprine hydrochloride
Dosage form: TABLET, FILM COATED
Route: ORAL
Labeler: Unit Dose Solutions, Inc.
Application: ANDA208170
Marketing category: ANDA
Marketing start: 2026-06-08
Substance: CYCLOBENZAPRINE HYDROCHLORIDE
Active strength: 10 mg/1
Pharmacologic classes: Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]
Listing certified through: 2027-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A208170-001	CYCLOBENZAPRINE HYDROCHLORIDE	CYCLOBENZAPRINE HYDROCHLORIDE	5MG	TABLET / ORAL	AB		2017-05-31
A208170-002	CYCLOBENZAPRINE HYDROCHLORIDE	CYCLOBENZAPRINE HYDROCHLORIDE	7.5MG	TABLET / ORAL	AB		2017-05-31
A208170-003	CYCLOBENZAPRINE HYDROCHLORIDE	CYCLOBENZAPRINE HYDROCHLORIDE	10MG	TABLET / ORAL	AB	RS	2017-05-31

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A208170-001	AB
A208170-002	AB
A208170-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 81 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A208170-001	CYCLOBENZAPRINE HYDROCHLORIDE	5MG	TABLET / ORAL	AB		2017-05-31	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A208170-002	CYCLOBENZAPRINE HYDROCHLORIDE	7.5MG	TABLET / ORAL	AB		2017-05-31	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A208170-003	CYCLOBENZAPRINE HYDROCHLORIDE	10MG	TABLET / ORAL	AB	RS	2017-05-31	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A208170-001	CYCLOBENZAPRINE HYDROCHLORIDE	5MG	TABLET / ORAL	AB		2017-05-31	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A208170-002	CYCLOBENZAPRINE HYDROCHLORIDE	7.5MG	TABLET / ORAL	AB		2017-05-31	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A208170-003	CYCLOBENZAPRINE HYDROCHLORIDE	10MG	TABLET / ORAL	AB	RS	2017-05-31	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A208170-001	CYCLOBENZAPRINE HYDROCHLORIDE	5MG	TABLET / ORAL	AB		2017-05-31	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A208170-002	CYCLOBENZAPRINE HYDROCHLORIDE	7.5MG	TABLET / ORAL	AB		2017-05-31	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A208170-003	CYCLOBENZAPRINE HYDROCHLORIDE	10MG	TABLET / ORAL	AB	RS	2017-05-31	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A208170-001	CYCLOBENZAPRINE HYDROCHLORIDE	5MG	TABLET / ORAL	AB		2017-05-31	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A208170-002	CYCLOBENZAPRINE HYDROCHLORIDE	7.5MG	TABLET / ORAL	AB		2017-05-31	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A208170-003	CYCLOBENZAPRINE HYDROCHLORIDE	10MG	TABLET / ORAL	AB		2017-05-31	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A208170-001	CYCLOBENZAPRINE HYDROCHLORIDE	5MG	TABLET / ORAL	AB		2017-05-31	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A208170-002	CYCLOBENZAPRINE HYDROCHLORIDE	7.5MG	TABLET / ORAL	AB		2017-05-31	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A208170-003	CYCLOBENZAPRINE HYDROCHLORIDE	10MG	TABLET / ORAL	AB	RS	2017-05-31	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A208170-001	CYCLOBENZAPRINE HYDROCHLORIDE	5MG	TABLET / ORAL	AB		2017-05-31	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A208170-002	CYCLOBENZAPRINE HYDROCHLORIDE	7.5MG	TABLET / ORAL	AB		2017-05-31	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A208170-003	CYCLOBENZAPRINE HYDROCHLORIDE	10MG	TABLET / ORAL	AB	RS	2017-05-31	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A208170-001	CYCLOBENZAPRINE HYDROCHLORIDE	5MG	TABLET / ORAL	AB		2017-05-31	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A208170-002	CYCLOBENZAPRINE HYDROCHLORIDE	7.5MG	TABLET / ORAL	AB		2017-05-31	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A208170-003	CYCLOBENZAPRINE HYDROCHLORIDE	10MG	TABLET / ORAL	AB	RS	2017-05-31	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A208170-001	CYCLOBENZAPRINE HYDROCHLORIDE	5MG	TABLET / ORAL	AB		2017-05-31	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	A208170-002	CYCLOBENZAPRINE HYDROCHLORIDE	7.5MG	TABLET / ORAL	AB		2017-05-31	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	A208170-003	CYCLOBENZAPRINE HYDROCHLORIDE	10MG	TABLET / ORAL	AB	RS	2017-05-31	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A208170-001	CYCLOBENZAPRINE HYDROCHLORIDE	5MG	TABLET / ORAL	AB		2017-05-31	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	A208170-002	CYCLOBENZAPRINE HYDROCHLORIDE	7.5MG	TABLET / ORAL	AB		2017-05-31	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	A208170-003	CYCLOBENZAPRINE HYDROCHLORIDE	10MG	TABLET / ORAL	AB	RS	2017-05-31	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A208170-001	CYCLOBENZAPRINE HYDROCHLORIDE	5MG	TABLET / ORAL	AB		2017-05-31	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	A208170-002	CYCLOBENZAPRINE HYDROCHLORIDE	7.5MG	TABLET / ORAL	AB		2017-05-31	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	A208170-003	CYCLOBENZAPRINE HYDROCHLORIDE	10MG	TABLET / ORAL	AB	RS	2017-05-31	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A208170-001	CYCLOBENZAPRINE HYDROCHLORIDE	5MG	TABLET / ORAL	AB		2017-05-31	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A208170-002	CYCLOBENZAPRINE HYDROCHLORIDE	7.5MG	TABLET / ORAL	AB		2017-05-31	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A208170-003	CYCLOBENZAPRINE HYDROCHLORIDE	10MG	TABLET / ORAL	AB		2017-05-31	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A208170-001	CYCLOBENZAPRINE HYDROCHLORIDE	5MG	TABLET / ORAL	AB		2017-05-31	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A208170-002	CYCLOBENZAPRINE HYDROCHLORIDE	7.5MG	TABLET / ORAL	AB		2017-05-31	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A208170-003	CYCLOBENZAPRINE HYDROCHLORIDE	10MG	TABLET / ORAL	AB		2017-05-31	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A208170-001	CYCLOBENZAPRINE HYDROCHLORIDE	5MG	TABLET / ORAL	AB		2017-05-31	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A208170-002	CYCLOBENZAPRINE HYDROCHLORIDE	7.5MG	TABLET / ORAL	AB		2017-05-31	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A208170-003	CYCLOBENZAPRINE HYDROCHLORIDE	10MG	TABLET / ORAL	AB		2017-05-31	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A208170-001	CYCLOBENZAPRINE HYDROCHLORIDE	5MG	TABLET / ORAL	AB		2017-05-31	`6a51e52b5d6a…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 81 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A208170-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A208170-002	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A208170-003	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A208170-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A208170-002	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A208170-003	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A208170-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A208170-002	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A208170-003	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A208170-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A208170-002	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A208170-003	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A208170-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A208170-002	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A208170-003	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A208170-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A208170-002	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A208170-003	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A208170-001	AB	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A208170-002	AB	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A208170-003	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A208170-001	AB	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	A208170-002	AB	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	A208170-003	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A208170-001	AB	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	A208170-002	AB	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	A208170-003	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A208170-001	AB	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	A208170-002	AB	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	A208170-003	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A208170-001	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A208170-002	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A208170-003	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A208170-001	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A208170-002	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A208170-003	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A208170-001	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A208170-002	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A208170-003	AB	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A208170-001	AB	1	`6a51e52b5d6a…`

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 3 · 57 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
CYCLOBENZAPRINE HYDROCHLORIDE	CYCLOBENZAPRINE HYDROCHLORIDE	REMEDYREPACK INC.	f2eb32c3-3da0-4938-9ed9-ea8420450fde	2026-07-27	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208170 application number: ANDA208170
CYCLOBENZAPRINE HYDROCHLORIDE	CYCLOBENZAPRINE HYDROCHLORIDE	TruPharma LLC	08adc97f-feef-46fb-ac75-f015b4f3a43a	2026-07-17	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208170 application number: ANDA208170
Cyclobenzaprine Hydrochloride	CYCLOBENZAPRINE HYDROCHLORIDE	NuCare Pharmaceuticals, Inc.	4ee4feec-4590-fa7f-e063-6394a90a5550	2026-07-17	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208170 application number: ANDA208170
CYCLOBENZAPRINE HYDROCHLORIDE	CYCLOBENZAPRINE HYDROCHLORIDE	HAWAII REPACK, INC.	cf5d4de9-79c3-4935-be69-89e98d7b54cc	2026-07-03	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208170 application number: ANDA208170
CYCLOBENZAPRINE HYDROCHLORIDE	CYCLOBENZAPRINE HYDROCHLORIDE	Proficient Rx LP	dfe7288c-a477-4f32-a9ab-00cc981a1a57	2026-07-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208170 application number: ANDA208170
CYCLOBENZAPRINE HYDROCHLORIDE	CYCLOBENZAPRINE HYDROCHLORIDE	REMEDYREPACK INC.	5d536e88-62be-45bd-bd09-0efc53fe12b9	2026-06-09	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208170 application number: ANDA208170
CYCLOBENZAPRINE HYDROCHLORIDE	CYCLOBENZAPRINE HYDROCHLORIDE	Unit Dose Solutions, Inc.	53bef1ab-55c0-cc52-e063-6394a90a12b3	2026-06-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208170 application number: ANDA208170 ndc (package): 87441-010-01 ndc (product): 87441-010 ndc11 (package): 87441001001
CYCLOBENZAPRINE HYDROCHLORIDE	CYCLOBENZAPRINE HYDROCHLORIDE	ST. MARY'S MEDICAL PARK PHARMACY	fe81c68d-a579-4fe9-e053-6294a90a7bc0	2026-05-29	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208170 application number: ANDA208170
CYCLOBENZAPRINE HYDROCHLORIDE	CYCLOBENZAPRINE HYDROCHLORIDE	ST. MARY'S MEDICAL PARK PHARMACY	00b20a8c-debd-e930-e063-6394a90a7ed0	2026-05-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208170 application number: ANDA208170
CYCLOBENZAPRINE HYDROCHLORIDE	CYCLOBENZAPRINE HYDROCHLORIDE	Coupler LLC	5023b8a5-c9df-84a4-e063-6294a90a9606	2026-04-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208170 application number: ANDA208170
CYCLOBENZAPRINE HYDROCHLORIDE	CYCLOBENZAPRINE HYDROCHLORIDE	QPharma, Inc.	4dcbdf8f-37ce-0f90-e063-6394a90ae83c	2026-04-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208170 application number: ANDA208170
CYCLOBENZAPRINE HYDROCHLORIDE	CYCLOBENZAPRINE HYDROCHLORIDE	REMEDYREPACK INC.	8bef97d4-1b92-4316-8733-7751d627230f	2026-04-09	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208170 application number: ANDA208170
Cyclobenzaprine Hydrochloride	CYCLOBENZAPRINE HYDROCHLORIDE	NuCare Pharmaceuticals, Inc.	2f89c8f6-7f3c-8396-e063-6294a90a643e	2026-04-06	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208170 application number: ANDA208170
CYCLOBENZAPRINE HYDROCHLORIDE	CYCLOBENZAPRINE HYDROCHLORIDE	Sportpharm LLC	24653b10-bdf0-47c5-a1f4-dc25f3b86032	2026-04-03	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208170 application number: ANDA208170
CYCLOBENZAPRINE HYDROCHLORIDE	CYCLOBENZAPRINE HYDROCHLORIDE	Preferred Pharmaceuticals Inc.	e4e8bab3-c5e7-4d2b-9692-ee6c6799b120	2026-04-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208170 application number: ANDA208170
CYCLOBENZAPRINE HYDROCHLORIDE	CYCLOBENZAPRINE HYDROCHLORIDE	Preferred Pharmaceuticals Inc.	e343fd12-1ca2-418a-b690-f3e8f567596d	2026-04-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208170 application number: ANDA208170
Cyclobenzaprine Hydrochloride	CYCLOBENZAPRINE HYDROCHLORIDE	Direct_Rx	15aad4af-5c05-be36-e063-6294a90a9bb3	2026-03-05	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208170 application number: ANDA208170
Cyclobenzaprine Hydrochloride	CYCLOBENZAPRINE HYDROCHLORIDE	NuCare Pharmaceuticals, Inc.	4c3a3b4f-7b2b-3fe9-e063-6394a90aae47	2026-03-04	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208170 application number: ANDA208170
CYCLOBENZAPRINE HYDROCHLORIDE	CYCLOBENZAPRINE HYDROCHLORIDE	Bryant Ranch Prepack	dc3cc6b6-c692-4986-8ff7-3a6cd8c85cb2	2026-03-04	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208170 application number: ANDA208170
CYCLOBENZAPRINE HYDROCHLORIDE	CYCLOBENZAPRINE HYDROCHLORIDE	Asclemed USA, Inc.	06da53af-5b46-4e32-a64c-9677e27ae229	2026-02-14	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208170 application number: ANDA208170

Additional Listing Data#

Finished product: Yes
Brand name base: CYCLOBENZAPRINE HYDROCHLORIDE
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
CYCLOBENZAPRINE HYDROCHLORIDE	10 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
0VE05JYS2P	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
828348	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
53bef1ab-55c0-cc52-e063-6394a90a12b3	Available on FDA.report

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
0VE05JYS2P	CYCLOBENZAPRINE HYDROCHLORIDE	6202-23-9	CYCLOBENZAPRINE HYDROCHLORIDE

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Sample	Status
87441-010-01	87441001001	30 TABLET, FILM COATED in 1 BLISTER PACK (87441-010-01)	2026-06-08	0	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Cyclobenzaprine hydrochloride, USP	Unit Dose Solutions, Inc.	2026-06-08	HUMAN PRESCRIPTION DRUG LABEL	1